Sensing mycobacteria through unconventional pathways
Journal of Clinical Investigation · 2025
DOI: 10.1172/jci190230 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Investigation, 2025. Verfasst von Catarina F Almeida und 1 weiteren Autor:innen. Hauptthemen laut MEDLINE: Mycobacterium tuberculosis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Approximately one-quarter of the global population is estimated to be infected with Mycobacterium tuberculosis. New developments in vaccine design and therapeutics are urgently needed, particularly in the face of multidrug-resistant tuberculosis (TB). In this issue of the JCI, Sakai and colleagues used a multidisciplinary approach to determine that trehalose-6-monomycolate (TMM), a mycobacterial cell wall lipid, serves as a T cell antigen presented by CD1b. CD1b-TMM-specific T cells were characterized by conserved T cell receptor features and were present at elevated frequencies in individuals with active TB disease. These findings highlight the dual role of TMM in stimulating both innate and adaptive immunity and broaden our understanding of CD1-mediated lipid recognition by unconventional T cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Zitieren
APA
Almeida, C. F., & Juno, J. A. (2025). Sensing mycobacteria through unconventional pathways. Journal of Clinical Investigation. https://doi.org/10.1172/jci190230
Vancouver
Almeida CF, Juno JA. Sensing mycobacteria through unconventional pathways. Journal of Clinical Investigation. 2025. doi:10.1172/jci190230
BibTeX
@article{Almeida2025,
author = {Almeida, Catarina F and Juno, Jennifer A},
title = {Sensing mycobacteria through unconventional pathways},
journal = {Journal of Clinical Investigation},
year = {2025},
doi = {10.1172/jci190230}
}
EUVIMED